DENBY WILLIAM C 4
4 · Adamis Pharmaceuticals Corp · Filed May 28, 2019
Insider Transaction Report
Form 4
DENBY WILLIAM C
Director
Transactions
- Purchase
Common Stock
2019-05-24$1.60/sh+6,250$9,997→ 108,750 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions at prices ranging from $1.595 to $1.60, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.